I thank Drs Milting and Klauke for reporting further characterization of this DSG2 allele. As they noted, our study group included a desmoglein-2 mutation, E712K which corresponds to the more widely accepted sequence annotation as E713K.1 Although we were not able to reference the primary report of every sequence alteration in Figure 2, Biedermann and colleagues previously reported that E712K is over-represented among individuals with familial gastric cancer compared to those with sporadic gastric cancer, suggesting a pathogenic role for this variant.2 In our Review, we attempted to include all published sequence variants with purported pathogenic effects and we did not include our own unpublished data.
Since then, we have assessed the prevalence of this allele in our own ARVD/C cohort as well as 200 North American Caucasian controls from Coriell Institute. We agree with Drs Milting and Klauke that this variant is a common SNP among Caucasians and is not likely pathogenic among individuals with ARVD/C.
References
Awad MM et al. (2008) Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med 5: 258–267
Biedermann K et al. (2005) Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer. J Pathol 207: 199–206
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Judge, D. E713K in desmoglein-2 and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Rev Cardiol 5, E2 (2008). https://doi.org/10.1038/ncpcardio1351
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1351